Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid Arthritis

Cansu B., ÜSKÜDAR CANSU D., KAŞİFOĞLU T., Gulbas Z., KORKMAZ C.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.17, no.1, pp.14-17, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.1097/rhu.0b013e318204a587
  • Journal Name: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.14-17
  • Keywords: adiponectin, acute-phase-response reactants, rheumatoid arthritis, disease activity, INSULIN-RESISTANCE, RISK, LEPTIN
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background: Adiponectin is an adipocyte-derived adipokine with immunosuppressive and anti-inflammatory properties. It also decreases expression of adhesion molecules. In terms of its relationship with acute-phase reactants, there are conflicting results in patients with rheumatoid arthritis (RA).